Quantinno Capital Management LP Sells 74,016 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Quantinno Capital Management LP lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 75.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,677 shares of the pharmacy operator's stock after selling 74,016 shares during the period. Quantinno Capital Management LP's holdings in Walgreens Boots Alliance were worth $212,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of WBA. Blue Trust Inc. grew its holdings in Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator's stock worth $28,000 after acquiring an additional 1,081 shares during the last quarter. Continuum Advisory LLC boosted its holdings in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator's stock worth $30,000 after purchasing an additional 1,020 shares during the period. Sentry Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance in the third quarter worth about $30,000. Eastern Bank purchased a new position in Walgreens Boots Alliance during the 3rd quarter valued at about $33,000. Finally, Strategic Investment Solutions Inc. IL bought a new position in Walgreens Boots Alliance during the 2nd quarter valued at approximately $34,000. Institutional investors own 58.59% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have commented on WBA shares. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating for the company in a report on Tuesday, October 22nd. JPMorgan Chase & Co. lowered their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an "overweight" rating for the company in a report on Friday, August 30th. Barclays upped their target price on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an "underweight" rating in a report on Wednesday, October 16th. Morgan Stanley decreased their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating for the company in a research report on Friday, October 11th. Finally, Jefferies Financial Group dropped their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating on the stock in a research report on Wednesday, October 23rd. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of "Hold" and an average target price of $12.58.

Walgreens Boots Alliance Stock Down 2.1 %

WBA stock traded down $0.21 during trading on Tuesday, hitting $9.97. 31,016,240 shares of the stock traded hands, compared to its average volume of 18,179,566. The stock has a market cap of $8.62 billion, a price-to-earnings ratio of -0.96, a price-to-earnings-growth ratio of 1.36 and a beta of 0.66. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $27.05. The firm's 50 day moving average is $9.29 and its two-hundred day moving average is $10.65.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter last year, the firm earned $0.67 earnings per share. The firm's quarterly revenue was up 5.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date was Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 10.03%. Walgreens Boots Alliance's dividend payout ratio (DPR) is presently -9.99%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.